24.6 C
New York
Sunday, June 14, 2026

Tag: public health

newssourceFORcompanyinformationcontent1marketreleases

The Dot Corp Achieves ISO 9001:2015 Certification, Reinforcing Leadership in Healthcare Fulfillment and Lab Testing Logistics

IRVINE, Calif., Aug. 11, 2025 /PRNewswire/ -- The Dot Corp. is proud to announce it has earned ISO 9001:2015 certification, further solidifying its position...

Idorsia publishes interim results of repurchase offer for its 2025 and 2028 convertible bonds

Ad hoc announcement pursuant to Art. 53 LR

60 Global Rising Stars from 1,200 Universities will Converge in Singapore for SMU’s 12th Lee Kuan Yew Competition Grand Finals

60 finalists for SG60 milestone edition selected by an international panel of judges and visionary partnersFocus on empowering Urban Solutions and Sustainability to solve...

Western Union to Acquire International Money Express, Inc.

Strategic acquisition strengthens North America retail presence and operating model, expands Intermex beyond its historically high growth Latin America corridors, and is expected to accelerate digital new customer acquisition 
Strategic acquisition strengthens North America retail presence and operating model, expands Intermex beyond its historically high growth Latin America corridors, and is expected to accelerate digital new customer acquisition

DDB Technology Redefines Innovation by Transforming Business Models, Not Just Products

NEW YORK, Aug. 9, 2025 /PRNewswire/ -- At a time when the term "innovation" is often confined to gadgets and features, DDB Technology, LLC...

Anbio Biotechnology Responds to Global Outbreaks with Chikungunya Rapid Test and New 15-Minute Ultra-Fast PCR System

Covering both mosquito-borne diseases and emerging respiratory pathogens, Anbio continues to advance point-of-care diagnostics for timely outbreak detection worldwide. FRANKFURT, Germany, Aug. 8, 2025 /PRNewswire/...

Anbio Biotechnology Responds to Global Outbreaks with Chikungunya Rapid Test and New 15-Minute Ultra-Fast PCR System

Covering both mosquito-borne diseases and emerging respiratory pathogens, Anbio continues to advance point-of-care diagnostics for timely outbreak detection worldwide. 
Covering both mosquito-borne diseases and emerging respiratory pathogens, Anbio continues to advance point-of-care diagnostics for timely outbreak detection worldwide.

Wisconsin Recognizes Autonomy of Advanced Practice Registered Nurses, Including CRNAs, with New State Law

ROSEMONT, Ill., Aug. 8, 2025 /PRNewswire/ -- (AANA) -- Wisconsin recently enacted legislation that allows more autonomy for Advanced Practice Registered Nurses (APRNs), including...

Public health notice: Outbreak of Salmonella infections linked to various brands of pistachios and pistachio-containing products

August 8, 2025: Update OTTAWA, ON, Aug. 8, 2025 /CNW/ - This outbreak investigation is ongoing. The public health notice will be updated as the investigation...

Cape Cod Healthcare Advanced Practice Providers File for NLRB Election After Seeking Union Recognition to Strengthen Voice in Patient Care and Working Conditions

Nurse Practitioners, Physician Assistants, and Certified Nurse Midwives at Cape Cod Healthcare move to join the MNA for an equal voice in clinical decisions CAPE...

Dorel Reports Second Quarter 2025 Results

MONTRÉAL, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Dorel Industries Inc. (TSX: DII.B, DII.A) today announced its financial results for the second quarter and six months ended June 30, 2025.

Aurora Cannabis Inc. Announces Results of 2025 Annual General and Special Meeting

NASDAQ | TSX: ACB EDMONTON, AB, Aug. 8, 2025 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), a leading Canada-based...

Aurora Cannabis Inc. Announces Results of 2025 Annual General and Special Meeting

NASDAQ | TSX: ACB EDMONTON, AB, Aug. 8, 2025 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), a leading Canada-based...

Edesa Biotech Reports Fiscal 3rd Quarter 2025 Results

TORONTO, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, today reported financial results for the three and nine months ended June 30, 2025 and provided an update on its business.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsPublic health

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers